|
T1272L |
Cytarabine hydrochloride
|
Ara-C hydrochloride,Cytosine Arabinoside hydrochloride |
DNA/RNA Synthesis
|
|
Cytarabine hydrochloride (Ara-C hydrochloride) is a nucleoside analog that causes S phase cell cycle arrest and inhibits DNA polymerase. Cytarabine inhibits DNA synthesis with an IC 50 of 16 nM. Cytarabine hydrochloride ... |
|
T38718 |
Cytarabine triphosphate
|
Cytarabine triphosphate,Ara-CTP |
|
|
Cytarabine triphosphate (Ara-CTP), a competitive inhibitor of DNA synthesis and an active metabolite of Cytarabine, exhibits predictive potential for leukemic blasts' chemosensitivity to Cytarabine through intracellular ... |
|
T15009 |
Elacytarabine
|
5'-Oleoyl cytosine arabinoside,5'-O-(Elaidoyl) 1-beta-D-arabinofuranosylcytosine,5'-Oleoyl cytarabine,CP 4055 |
Others
|
|
Elacytarabine (M7594 0037), a lipid-conjugated derivative of the nucleoside analog cytarabine, is an antineoplastic drug. It has cytotoxicity in solid tumors. |
|
T15343 |
Fosteabine
|
YNK 01,Cytarabine ocfosfate |
Others
|
|
Fosteabine is an oral and prodrug analog of cytarabine. It is resistant to deoxycytidine deaminase. |
|
T31088 |
CPX-351
|
Cytarabine/daunonubicin,Vyxeos,CPX 351,Daunonubicin/cytarabine |
|
|
CPX-351 is a Liposomal-encapsulated combination of daunorubicin and cytarabine for the treatment of newly diagnosed tAML or AML with myelodysplasia-related changes (AML-MRCs). |
|
T29643 |
Adamantoylcytarabine
|
Adamantoyl cytarabine,Adam CA |
|
|
Adamantoylcytarabine is abioactive chemical. |
|
T27342L |
Flurocitabine HCl
|
Flurocitabine HCl(37717-21-8 Free base) |
Others
|
|
Flurocitabine HCl is a fluorinated anhydride analog of cytarabine, which is partially hydrolyzed in vivo to two active antitumor substances (arabinosyl-fluorouracil (ara-FC) and arabinosyl-fluorouracil (ara-FU)).Flurocit... |
|
T21161 |
Ancitabine
|
|
|
|
Ancitabine, a congener of cyterabine, is metabolized to cytarabine, thereby maintains a more constant antineoplastic action. |
|
T79224 |
Ara-SH
|
|
Apoptosis
|
|
Ara-SH, a derivative of Cytarabine with a mercaptopropionic acid substitution, serves as the initiator for the self-assembly of a smart, co-loaded Cytarabine and Venetoclax nanoparticle (AV-NP), demonstrating notable syn... |
|
T11956L |
MBC-11
|
|
Others
|
|
MBC-11 is a first-in-class conjugate of the bone-targeting bisphosphonate etidronate covalently linked to the antimetabolite cytarabine (araC). It also has the potential to treat tumor-induced bone disease (TIBD). |
|
T11956 |
MBC-11 triethylamine
|
|
Others
|
|
MBC-11 triethylamine has potential to treat tumor-induced bone disease (TIBD), is a first-in-class conjugate of the bone-targeting bisphosphonate etidronate covalently linked to the antimetabolite cytarabine (araC). |
|
T68917 |
Fazarabine
|
|
|
|
Fazarabine, also known as Kymarabine, is an orally-active pyrimidine analogue of an aza-substituted cytidine in which the ribose moiety is replaced by an arabinose sugar. Similar in action to cytarabine, fazarabine is ph... |
|
T71654 |
APcK110
|
|
|
|
APcK110 is a novel Kit inhibitor . APcK110 inhibits proliferation of the mastocytosis cell line HMC1.2 and the SCF-responsive cell line OCI/AML3 in a dose-dependent manner . APcK110 is a more potent inhibitor of OCI/AML3... |
